CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

New England Journal of Medicine
Original article

iEvac-Z, an Inactivated Ebola Vaccine — Phase 1 Study in Japan

Phase 1iEvac-ZNeutral
AI Analysis

Summary

iEvac-Z, an inactivated Ebola vaccine, is being evaluated in a Phase 1 study in Japan, as reported in the New England Journal of Medicine.

Clinical Trial Data

Phase

Phase 1

Importance:5/10
Sentiment:
0.00
vaccineebolaphase_1japaninactivated
Related Companies

Read the original article

Published by New England Journal of Medicine on July 29, 2026 9:01 AM

Read Original